This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Hadasit Medical Research Services and Development Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2014.
Company Filing History:
1 out of 180 
1 out of 910 
Years Active: 2014
Title: Adel Jabbour: Innovator in Anti-Biofilm Agents
Introduction
Adel Jabbour is a notable inventor based in Nazareth Illit, Israel. She has made significant contributions to the field of biomedical research, particularly in the development of anti-biofilm agents. Her innovative work focuses on creating novel agents that exhibit anti-biofilm formation activity while remaining non-cytotoxic.
Latest Patents
Adel Jabbour holds a patent for anti-biofilm agents. This patent describes novel agents that prevent and reduce the formation of microbial biofilms and disrupt existing biofilms. The agents include thiazolidine-2,4-diones (TZDs), pyrrolidine-2,5-diones (PYDs), imidazolidine-2,4-diones, and oxazolidine-2,4-diones, which are substituted by an alkyl chain containing 7-20 carbon atoms. This innovative approach has the potential to significantly impact medical treatments and improve patient outcomes.
Career Highlights
Throughout her career, Adel Jabbour has worked with prominent organizations such as Hadasit Medical Research Services and Development Ltd. and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Adel has collaborated with esteemed colleagues, including Doron Steinberg and Itzhack Polacheck. These partnerships have fostered a collaborative environment that enhances the development of her innovative solutions.
Conclusion
Adel Jabbour's work in the field of anti-biofilm agents showcases her dedication to advancing biomedical research. Her innovative patents and collaborations highlight her significant contributions to the scientific community.